Cargando…
The attitude of patients with progressive ataxias towards clinical trials
BACKGROUND: The development of new therapies may rely on the conduct of human experimentation as well as later clinical trials of therapeutic interventions. Ethical considerations seek to protect the patient from risk but few have sought to ascertain the attitude to such risk of patients with progre...
Autores principales: | Thomas-Black, Gilbert, Dumitrascu, Andrada, Garcia-Moreno, Hector, Vallortigara, Julie, Greenfield, Julie, Hunt, Barry, Walther, Susan, Wells, Mackenzie, Lynch, David R., Montgomery, Hugh, Giunti, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729009/ https://www.ncbi.nlm.nih.gov/pubmed/34983593 http://dx.doi.org/10.1186/s13023-021-02091-x |
Ejemplares similares
-
Diagnosis and management of progressive ataxia in adults
por: de Silva, Rajith Nilantha, et al.
Publicado: (2019) -
Guidelines on the diagnosis and management of the progressive ataxias
por: de Silva, Rajith, et al.
Publicado: (2019) -
Patient pathways for rare diseases in Europe: ataxia as an example
por: Vallortigara, Julie, et al.
Publicado: (2023) -
Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia
por: Zeitlberger, Anna M., et al.
Publicado: (2018) -
Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
por: Koohi, Nehzat, et al.
Publicado: (2021)